Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Critical Elements Lithium Co. stock logo
CRE
Critical Elements Lithium
C$0.98
C$0.70
C$0.55
C$2.37
C$213.42M0.54205,140 shs60,443 shs
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
C$3.07
C$1.66
C$4.85
C$553.23MN/A669,999 shs1.96 million shs
McEwen Mining Inc stock logo
MUX
McEwen Mining
$11.76
+1.3%
$9.75
$5.92
$12.50
$581.41M1.48956,739 shs469,206 shs
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$123.05
-0.8%
$127.20
$75.56
$138.28
$552.19B0.433.91 million shs5.93 million shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Critical Elements Lithium Co. stock logo
CRE
Critical Elements Lithium
0.00%+10.11%+44.12%+36.11%-56.05%
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
0.00%0.00%0.00%0.00%0.00%
McEwen Mining Inc stock logo
MUX
McEwen Mining
+1.20%-4.00%+6.04%+59.57%+35.02%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
-0.72%-2.98%-3.08%+8.25%+193.45%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Critical Elements Lithium Co. stock logo
CRE
Critical Elements Lithium
0.6769 of 5 stars
3.50.00.80.00.60.00.0
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/AN/AN/AN/AN/AN/AN/AN/A
McEwen Mining Inc stock logo
MUX
McEwen Mining
0.5583 of 5 stars
1.52.00.00.02.60.81.3
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
2.247 of 5 stars
1.43.02.50.02.50.03.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Critical Elements Lithium Co. stock logo
CRE
Critical Elements Lithium
3.00
BuyC$3.93301.36% Upside
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/AN/AN/AN/A
McEwen Mining Inc stock logo
MUX
McEwen Mining
3.00
Buy$11.921.33% Upside
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
2.75
Moderate Buy$133.608.57% Upside

Current Analyst Ratings

Latest MUX, NVO, CRE, and KDX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/18/2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$160.00
4/12/2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$163.00
4/1/2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$160.00
3/20/2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$160.00
3/4/2024
McEwen Mining Inc stock logo
MUX
McEwen Mining
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$18.50 ➝ $13.00
2/20/2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$140.00
2/14/2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$140.00
(Data available from 5/4/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Critical Elements Lithium Co. stock logo
CRE
Critical Elements Lithium
N/AN/AC$0.07 per share13.31C$0.33 per shareN/A
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/AN/AN/AN/AN/AN/A
McEwen Mining Inc stock logo
MUX
McEwen Mining
$166.23M3.50$1.74 per share6.75$10.16 per share1.16
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$33.71B16.38$2.99 per share41.19$3.45 per share35.67

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Critical Elements Lithium Co. stock logo
CRE
Critical Elements Lithium
-C$3.92M-C$0.02N/AN/AN/A-5.84%-6.31%7/18/2024 (Estimated)
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/AN/A0.00N/AN/AN/AN/AN/AN/A
McEwen Mining Inc stock logo
MUX
McEwen Mining
$55.30M$1.1410.32N/A32.92%19.20%14.62%5/13/2024 (Estimated)
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$12.15B$2.9042.4330.092.0736.56%92.21%29.87%8/8/2024 (Estimated)

Latest MUX, NVO, CRE, and KDX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/29/2024Q4 2023
McEwen Mining Inc stock logo
MUX
McEwen Mining
-$0.32$2.90+$3.22$2.90$53.00 million$58.68 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Critical Elements Lithium Co. stock logo
CRE
Critical Elements Lithium
N/AN/AN/AN/AN/A
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/AN/AN/AN/AN/A
McEwen Mining Inc stock logo
MUX
McEwen Mining
N/AN/AN/AN/AN/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$1.331.08%+16.52%45.86%1 Years

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Critical Elements Lithium Co. stock logo
CRE
Critical Elements Lithium
0.32
18.49
11.23
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/AN/AN/A
McEwen Mining Inc stock logo
MUX
McEwen Mining
0.08
1.76
1.09
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.19
0.82
0.64

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Critical Elements Lithium Co. stock logo
CRE
Critical Elements Lithium
3.97%
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/A
McEwen Mining Inc stock logo
MUX
McEwen Mining
17.03%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
11.54%

Insider Ownership

CompanyInsider Ownership
Critical Elements Lithium Co. stock logo
CRE
Critical Elements Lithium
4.27%
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/A
McEwen Mining Inc stock logo
MUX
McEwen Mining
17.40%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.07%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Critical Elements Lithium Co. stock logo
CRE
Critical Elements Lithium
N/A217.78 millionN/ANot Optionable
Klondex Mines Ltd. stock logo
KDX
Klondex Mines
N/A180.21 millionN/ANot Optionable
McEwen Mining Inc stock logo
MUX
McEwen Mining
42749.44 million40.84 millionOptionable
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
63,3704.49 billion4.48 billionOptionable

MUX, NVO, CRE, and KDX Headlines

SourceHeadline
Apple, Glencore, Sony, Novo Nordisk, Shell, Goldman Sach, GSK, Qualcomm, AMD, Starbucks, Amazon – Markets DefusedApple, Glencore, Sony, Novo Nordisk, Shell, Goldman Sach, GSK, Qualcomm, AMD, Starbucks, Amazon – Markets Defused
proactiveinvestors.co.uk - May 4 at 6:01 AM
Russell Investments Group Ltd. Sells 20,488 Shares of Novo Nordisk A/S (NYSE:NVO)Russell Investments Group Ltd. Sells 20,488 Shares of Novo Nordisk A/S (NYSE:NVO)
marketbeat.com - May 4 at 5:57 AM
Summit Global Investments Cuts Stock Holdings in Novo Nordisk A/S (NYSE:NVO)Summit Global Investments Cuts Stock Holdings in Novo Nordisk A/S (NYSE:NVO)
marketbeat.com - May 3 at 11:11 PM
Novo Nordisk A/S (NYSE:NVO) Trading Down 1%Novo Nordisk A/S (NYSE:NVO) Trading Down 1%
marketbeat.com - May 3 at 10:28 PM
3 Under-The-Radar Stocks That Could Be Worth Over $1 Trillion by 20303 Under-The-Radar Stocks That Could Be Worth Over $1 Trillion by 2030
investorplace.com - May 3 at 2:39 PM
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated personsNovo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
globenewswire.com - May 3 at 1:48 PM
The FTC Cracks Down On Novo Nordisks OzempicThe FTC Cracks Down On Novo Nordisk's Ozempic
seekingalpha.com - May 3 at 1:45 PM
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slideAmgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
cnbc.com - May 3 at 10:44 AM
MarketBeat Week in Review – 4/22 - 4/26MarketBeat Week in Review – 4/22 - 4/26
marketbeat.com - May 3 at 10:17 AM
Novo Nordisk continues to impress, says buyer CitiNovo Nordisk continues to impress, says buyer Citi
proactiveinvestors.co.uk - May 3 at 10:00 AM
Wegovy maker Novo Nordisk down 4%, heads for worst day since OctoberWegovy maker Novo Nordisk down 4%, heads for worst day since October
cnbc.com - May 3 at 9:09 AM
US FTC seeks more information on Novo Nordisk parent-Catalent dealUS FTC seeks more information on Novo Nordisk parent-Catalent deal
reuters.com - May 3 at 8:58 AM
Ventus Therapeutics Announces First Participant Dosed in Clinical Study with an NLRP3 Inhibitor Licensed Exclusively to Novo NordiskVentus Therapeutics Announces First Participant Dosed in Clinical Study with an NLRP3 Inhibitor Licensed Exclusively to Novo Nordisk
businesswire.com - May 3 at 8:00 AM
This Is a Huge Sigh of Relief for Novo Nordisk InvestorsThis Is a Huge Sigh of Relief for Novo Nordisk Investors
fool.com - May 3 at 7:00 AM
Novo Nordisk drops 5% after rival Amgen teases weight-loss drug dataNovo Nordisk drops 5% after rival Amgen teases weight-loss drug data
reuters.com - May 3 at 6:36 AM
Novo Nordisk A/S (NYSE:NVO) Receives Average Rating of "Moderate Buy" from BrokeragesNovo Nordisk A/S (NYSE:NVO) Receives Average Rating of "Moderate Buy" from Brokerages
americanbankingnews.com - May 3 at 2:42 AM
38,192 Shares in Novo Nordisk A/S (NYSE:NVO) Bought by Wesbanco Bank Inc.38,192 Shares in Novo Nordisk A/S (NYSE:NVO) Bought by Wesbanco Bank Inc.
marketbeat.com - May 3 at 12:09 AM
Buy Rating Affirmed for Novo Nordisk on Strong Product Performance and Market PositionBuy Rating Affirmed for Novo Nordisk on Strong Product Performance and Market Position
markets.businessinsider.com - May 2 at 8:59 PM
Market Chatter: Novo Nordisk, Eli Lillys Weight-Loss Drugs Get Price Cuts in UKMarket Chatter: Novo Nordisk, Eli Lilly's Weight-Loss Drugs Get Price Cuts in UK
finance.yahoo.com - May 2 at 8:59 PM
Novo Nordisk slides while Moderna pops: Tale of two pharma stocksNovo Nordisk slides while Moderna pops: Tale of two pharma stocks
finance.yahoo.com - May 2 at 8:59 PM
Weight Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy and MounjaroWeight Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy and Mounjaro
finance.yahoo.com - May 2 at 8:59 PM
Novo Nordisk A/S (NYSE:NVO)  Shares Down 3% Novo Nordisk A/S (NYSE:NVO) Shares Down 3%
marketbeat.com - May 2 at 3:24 PM
Novo Nordisk A/S 2024 Q1 - Results - Earnings Call PresentationNovo Nordisk A/S 2024 Q1 - Results - Earnings Call Presentation
seekingalpha.com - May 2 at 12:25 PM
Novo Nordisk Dips After Wegovy Sales Double, But Miss Analysts ForecastNovo Nordisk Dips After Wegovy Sales Double, But Miss Analysts' Forecast
finance.yahoo.com - May 2 at 10:58 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Critical Elements Lithium logo

Critical Elements Lithium

CVE:CRE
Critical Elements Lithium Corporation engages in the acquisition, exploration, and development of mining properties in Canada. The company explores for copper, zinc, gold, silver, nickel, lead, lithium, niobium, tantalum, platinum group, and rare earth elements. Its flagship project is the Rose Lithium-Tantalum project that consists of 473 claims covering a total area of 244.99 square kilometers located in the Eastmain greenstone belt. The company was formerly known as Critical Elements Corporation and changed its name to Critical Elements Lithium Corporation in June 2019. Critical Elements Lithium Corporation was incorporated in 2006 and is headquartered in Blainville, Canada.
Klondex Mines logo

Klondex Mines

TSE:KDX
Klondex Mines Ltd., together with its subsidiaries, acquires, explores, develops, and produces mineral properties in the United States and Canada. It primarily explores for gold and silver deposits. The company holds 100% interests in the Fire Creek mine covering approximately 19,000 acres located in Lander County; the Midas mine and ore milling facility covering approximately 30,000 acres situated in Elko County; and the Hollister mine approximately 18,000 acres located in Elko County. It also has 100% interests in the True North gold mine and mill covering approximately 39,868 hectares situated in Manitoba, Canada; and the Aurora mine and ore milling facility covering approximately 5,004 contiguous acres located in Nevada, as well as in the Ogama-Rockland property in Manitoba, Canada. The company was formerly known as Attila Resources Limited and changed its name to Klondex Mines Ltd. in October 1974. Klondex Mines Ltd. was founded in 1971 and is headquartered in Reno, Nevada.
McEwen Mining logo

McEwen Mining

NYSE:MUX
McEwen Mining Inc. engages in the exploration, development, production, and sale of gold and silver. It also explores for copper deposits. The company owns 100% interests in the El Gallo and Fenix projects located in Mexico; and the Black Fox Mine and Stock Mill, Grey Fox, and Froome and Tamarack properties in Canada. It also owns interests in the Fuller, Davidson-Tisdale, Buffalo Ankerite, and Paymaster exploration properties located in Canada; and a 49% interest in the San José mine located in Argentina. In addition, the company owns 100% interests in the Gold Bar and Tonkin properties located in Eureka County, Nevada; and interests in the Los Azules copper project located in the cordilleran region in the province of San Juan, Argentina. The company was formerly known as US Gold Corporation and changed its name to McEwen Mining Inc. in January 2012. McEwen Mining Inc. was founded in 1979 and is headquartered in Toronto, Canada.
Novo Nordisk A/S logo

Novo Nordisk A/S

NYSE:NVO
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.